The primate locus coeruleus and effects of clonidine on opiate withdrawal
- PMID: 6282817
The primate locus coeruleus and effects of clonidine on opiate withdrawal
Abstract
Studies of nonhuman primates suggested that the noradrenergic locus coeruleus (LC) may be involved as part of the neural substrate for a brain alarm function which includes attentiveness, arousal, anxiety, fear, terror, and the physiological correlates of these states. The studies compared the effects of electrical activation of tiny electrodes in the locus coeruleus with the effects of other agents and conditions which increased or decreased LC activity. The results suggested that the activation of the LC system is prevented by endogenous morphine-like substances and by opiates and that the opiate withdrawal syndrome is due to activation of this LC-noradrenergic system. Clonidine, which in low doses suppressed noradrenergic and LC activity, was therefore postulated to suppress opiate withdrawal signs and symptoms. The confirmation of this hypothesis in rats, monkeys and human subjects has added to the understanding of the mechanisms of opiate action and withdrawal.
Similar articles
-
Neuroanatomical sites of action of clonidine in opiate withdrawal: the locus coeruleus connection.Prog Clin Biol Res. 1981;71:285-98. Prog Clin Biol Res. 1981. PMID: 6276897 No abstract available.
-
Clonidine: inpatient studies from 1978 to 1981.J Clin Psychiatry. 1982 Jun;43(6 Pt 2):35-8. J Clin Psychiatry. 1982. PMID: 7085583
-
Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.J Pharmacol Exp Ther. 1999 Aug;290(2):881-92. J Pharmacol Exp Ther. 1999. PMID: 10411605
-
Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.Psychiatr Clin North Am. 1993 Mar;16(1):61-73. Psychiatr Clin North Am. 1993. PMID: 8456048 Review.
-
The sequential use of clonidine and naltrexone in the treatment of opiate addicts.Adv Alcohol Subst Abuse. 1984 Spring;3(3):19-39. doi: 10.1300/J251v03n03_03. Adv Alcohol Subst Abuse. 1984. PMID: 6388273 Review.
Cited by
-
Tourette syndrome: successful treatment with clonidine and oxycodone.J Neurol. 1986 Jun;233(3):178-9. doi: 10.1007/BF00314429. J Neurol. 1986. PMID: 3459810
-
Effects of Glycyrrhizae Radix on Repeated Restraint Stress-induced Neurochemical and Behavioral Responses.Korean J Physiol Pharmacol. 2010 Dec;14(6):371-6. doi: 10.4196/kjpp.2010.14.6.371. Epub 2010 Dec 31. Korean J Physiol Pharmacol. 2010. PMID: 21311677 Free PMC article.
-
Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats.Psychopharmacology (Berl). 1991;103(3):407-14. doi: 10.1007/BF02244297. Psychopharmacology (Berl). 1991. PMID: 2057541
-
Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.Intensive Care Med. 2005 Mar;31(3):380-7. doi: 10.1007/s00134-005-2579-3. Epub 2005 Feb 16. Intensive Care Med. 2005. PMID: 15714323 Clinical Trial.
-
Fucoidan prevents depression-like behavior in rats exposed to repeated restraint stress.J Nat Med. 2013 Jul;67(3):534-44. doi: 10.1007/s11418-012-0712-5. Epub 2012 Oct 23. J Nat Med. 2013. PMID: 23090005
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical